English

Interim report January–March 2021

Report this content
  • Revenue amounted to €317.2m (€238.8m), an increase of 32.8% with an organic growth of 39.7%.
  • Operating profit (EBIT) was €41.6m (€6.4m), representing an operating margin of 13.1% (2.7%).
  • Net profit amounted to €26.3m (€-2.5m), which represents a net profit margin of 8.3% (-1.0%).
  • EBITDA was €65.5m (€29.0m), an increase of 125.6%. EBITDA margin was 20.6% (12.2%).
  • EBITDAaL amounted to €52.9m (€16.8m), corresponding to an EBITDAaL margin of 16.7% (7.0%).
  • Net cash flow from operating activities was €57.7m (€36.6m).
  • Basic/diluted earnings per share were €0.174
    (€-0.006).
  • Covid-19-pandemic had a net positive impact on operating performance.
 

REVENUE AND EARNINGS

€ millions (€m)

 Q1 2021 Q1 2020 Growth FY 2020
Revenue 317.2 238.8 33% 997.8
Operating profit (EBIT) 41.6 6.4 550% 61.3
Operating profit margin 13.1% 2.7% 6.1%
Net profit 26.3 -2.5 1,152% 27.3
Net profit margin 8.3% -1.0% 2.7%
Basic/diluted earnings per share, € 0.174 -0.006 3,000% 0.182
EBITDA 65.5 29.0 126% 157.5
EBITDA margin 20.6% 12.2% 15.8%
EBITDAaL 52.9 16.8 215% 108.5
EBITDAaL margin 16.7% 7.0% 10.9%
EBITA 44.1 8.9 396% 76.9
EBITA margin 13.9% 3.7% 7.7%

Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information.

This report has not been subject to review by the Company’s auditor.

This is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out below at 7.45 (CEST) on 29 April 2021. This interim report and other information about Medicover is available at www.medicover.com.

 

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
Phone: +46 70 303 32 72
E-mail: hanna.bjellquist@medicover.com

Conference call: A conference call for analysts and investors will be held today at 09.30 CEST. To listen in please register here. To ask questions please dial in and use code: 8975934
SE: 08-566 184 67        
DE: +49 (0) 305 200 2085
UK: +44 (0) 2071 928 338
US: +1 646 741 3167

 

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of EUR 998 million and more than 32,000 employees. For more information, go to www.medicover.com

Tags:

Interim report Medicover Fredrik Rågmark

Subscribe

Documents & Links